Resultats de la cerca - Perrot, Aurore

Revised international staging system allocation in the ICARIA‐MM study: Practical challenges and impact on outcome per Richardson, Paul G., Perrot, Aurore, Takamatsu, Hiroyuki

Obtenir text complet Obtenir text complet Obtenir text complet

Vaccination during the First Diagnosis of Multiple Myeloma: A Cohort Study of the French National Health Insurance Database per Tournaire, Guilhem, Conte, Cécile, Perrot, Aurore, Lapeyre-Mester, Maryse, Despas, Fabien

Obtenir text complet Obtenir text complet Obtenir text complet

Multiple Myeloma: Heterogeneous in Every Way per Schavgoulidze, Anaïs, Cazaubiel, Titouan, Perrot, Aurore, Avet-Loiseau, Hervé, Corre, Jill

Obtenir text complet Obtenir text complet Obtenir text complet

When dystrophic plasma cells do not recognize themselves in the mirror per Rieu, Jean‐Baptiste, Perrot, Aurore, Vergez, Francois, Largeaud, Laetitia, Corre, Jill

Obtenir text complet Obtenir text complet Obtenir text complet

Risk and Response-Adapted Treatment in Multiple Myeloma per Cazaubiel, Titouan, Mulas, Olga, Montes, Lydia, Schavgoulidze, Anaïs, Avet-Loiseau, Hervé, Corre, Jill, Perrot, Aurore

Obtenir text complet Obtenir text complet Obtenir text complet

Lactic acidosis and hypoglycemia as markers of disease progression of multiple myeloma: A case report per Ziegler, Caroline, Volkov, Lev, Marnai, Rémy, Courte, Guilhem, Cravoisy, Aurélie, Conrad, Marie, Nace, Lionel, Melone, Agnès, Perrot, Aurore, Gibot, Sébastien

Obtenir text complet Obtenir text complet Obtenir text complet

Variable BCL2/BCL2L1 ratio in multiple myeloma with t(11;14) per Cleynen, Alice, Samur, Mehmet, Perrot, Aurore, Buisson, Laure, Maheo, Sabrina, Fulciniti, Mariateresa, Attal, Michel, Munshi, Nikhil, Avet-Loiseau, Hervé, Corre, Jill

Obtenir text complet Obtenir text complet Obtenir text complet

Impact of post-brentuximab vedotin consolidation on relapsed/refractory CD30(+) Hodgkin lymphomas: a large retrospective study on 240 patients enrolled in the French Named-Patient... per Perrot, Aurore, Monjanel, Hélène, Bouabdallah, Réda, Quittet, Philippe, Sarkozy, Clémentine, Bernard, Marc, Stamatoullas, Aspasia, Borel, Cécile, Bouabdallah, Krimo, Nicolas-Virelizier, Emmanuelle, Fournier, Marion, Morschhauser, Franck, Brice, Pauline

Obtenir text complet Obtenir text complet Obtenir text complet

A unique proteomic profile on surface IgM ligation in unmutated chronic lymphocytic leukemia per Perrot, Aurore, Pionneau, Cédric, Nadaud, Sophie, Davi, Frédéric, Leblond, Véronique, Jacob, Frédéric, Merle-Béral, Hélène, Herbrecht, Raoul, Béné, Marie-Christine, Gribben, John G., Bahram, Seiamak, Vallat, Laurent

Obtenir text complet Obtenir text complet Obtenir text complet

Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow per Mazzotti, Céline, Buisson, Laure, Maheo, Sabrina, Perrot, Aurore, Chretien, Marie-Lorraine, Leleu, Xavier, Hulin, Cyrille, Manier, Salomon, Hébraud, Benjamin, Roussel, Murielle, Do Souto, Laura, Attal, Michel, Avet-Loiseau, Hervé, Corre, Jill

Obtenir text complet Obtenir text complet Obtenir text complet

Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia per Tomowiak, Cécile, Poulain, Stéphanie, Herbaux, Charles, Perrot, Aurore, Mahé, Béatrice, Morel, Pierre, Aurran, Thérèse, Tournilhac, Olivier, Leprêtre, Stéphane, Assaad, Souad, Villemagne, Bruno, Casasnovas, Olivier, Nollet, Delphine, Roos-Weil, Damien, Chevret, Sylvie, Leblond, Véronique

Obtenir text complet Obtenir text complet Obtenir text complet

Infradiaphragmatic Hodgkin lymphoma: a large series of patients staged with PET-CT per Rossi, Cédric, Mounier, Morgane, Brice, Pauline, Safar, Violaine, Nicolas-Virelizier, Emmanuelle, Rey, Philippe, Stamatoullas-Bastard, Aspasia, Alcantara, Marion, Chauchet, Adrien, Reboursière, Emilie, Filliatre, Lauriane, Perrot, Aurore, Garciaz, Sylvain, Salles, Gilles, Coiffier, Bertrand, Ghesquières, Hervé, Casasnovas, René-Olivier

Obtenir text complet Obtenir text complet Obtenir text complet

All-oral triplet combination of ixazomib, lenalidomide, and dexamethasone in newly diagnosed transplant-eligible multiple myeloma patients: final results of the phase II IFM 2013-0... per Touzeau, Cyrille, Perrot, Aurore, Roussel, Murielle, Karlin, Lionel, Benboubker, Lotfi, Jacquet, Caroline, Mohty, Mohamad, Facon, Thierry, Manier, Salomon, Chretien, Marie-Lorraine, Tiab, Mourad, Hulin, Cyrille, Leleu, Xavier, Loiseau, Hervé Avet, Dejoie, Thomas, Planche, Lucie, Attal, Michel, Moreau, Philippe

Obtenir text complet Obtenir text complet Obtenir text complet

Subgroup analysis of ICARIA‐MM study in relapsed/refractory multiple myeloma patients with high‐risk cytogenetics per Harrison, Simon J., Perrot, Aurore, Alegre, Adrian, Simpson, David, Wang, Ming Chung, Spencer, Andrew, Delimpasi, Sosana, Hulin, Cyrille, Sunami, Kazutaka, Facon, Thierry, Vlummens, Philip, Yong, Kwee, Campana, Frank, Inchauspé, Marlène, Macé, Sandrine, Risse, Marie‐Laure, van de Velde, Helgi, Richardson, Paul

Obtenir text complet Obtenir text complet Obtenir text complet

Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies per Cabannes‐Hamy, Aurélie, Peyrade, Frederic, Jardin, Fabrice, Emile, Jean‐François, Delwail, Vincent, Mounier, Nicolas, Haioun, Corinne, Perrot, Aurore, Fitoussi, Olivier, Lara, Diane, Delarue, Richard, André, Marc, Offner, Fritz, Ghesquières, Hervé, Pascal, Laurent, Soussain, Carole, Lazarovici, Julien, Schiano, Jean‐Marc, Gaulard, Philippe, Tilly, Hervé, Thieblemont, Catherine

Obtenir text complet Obtenir text complet Obtenir text complet

A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab per Mikhael, Joseph, Belhadj-Merzoug, Karim, Hulin, Cyrille, Vincent, Laure, Moreau, Philippe, Gasparetto, Cristina, Pour, Ludek, Spicka, Ivan, Vij, Ravi, Zonder, Jeffrey, Atanackovic, Djordje, Gabrail, Nashat, Martin, Thomas G., Perrot, Aurore, Bensfia, Samira, Weng, Qilong, Brillac, Claire, Semiond, Dorothée, Macé, Sandrine, Corzo, Kathryn P., Leleu, Xavier

Obtenir text complet Obtenir text complet Obtenir text complet

A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts per Ghesquières, Hervé, Larrabee, Beth R., Casasnovas, Olivier, Maurer, Matthew J., McKay, James D., Ansell, Stephen M., Montgomery, Dorothy, Asmann, Yan W., Farrell, Katrina, Verney, Aurélie, Slager, Susan L., Allmer, Cristine, Perrot, Aurore, Delarue, Richard, Habermann, Thomas M., Dupuis, Jehan, Link, Brian K., Canioni, Danielle, Dogan, Ahmet, Cozen, Wendy, Jarrett, Ruth F., Cerhan, James R., Salles, Gilles

Obtenir text complet Obtenir text complet Obtenir text complet

del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma per Corre, Jill, Perrot, Aurore, Caillot, Denis, Belhadj, Karim, Hulin, Cyrille, Leleu, Xavier, Mohty, Mohamad, Facon, Thierry, Buisson, Laure, Do Souto, Laura, Lannes, Romain, Dufrechou, Stephanie, Prade, Naïs, Orsini-Piocelle, Frederique, Voillat, Laurent, Jaccard, Arnaud, Karlin, Lionel, Macro, Margaret, Brechignac, Sabine, Dib, Mamoun, Sanhes, Laurence, Fontan, Jean, Clement-Filliatre, Lauriane, Marolleau, Jean-Pierre, Minvielle, Stephane, Moreau, Philippe, Avet-Loiseau, Hervé

Obtenir text complet Obtenir text complet Obtenir text complet

Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial per Perrot, Aurore, Facon, Thierry, Plesner, Torben, Usmani, Saad Z., Kumar, Shaji, Bahlis, Nizar J., Hulin, Cyrille, Orlowski, Robert Z., Nahi, Hareth, Mollee, Peter, Ramasamy, Karthik, Roussel, Murielle, Jaccard, Arnaud, Delforge, Michel, Karlin, Lionel, Arnulf, Bertrand, Chari, Ajai, He, Jianming, Ho, Kai Fai, Van Rampelbergh, Rian, Uhlar, Clarissa M., Wang, Jianping, Kobos, Rachel, Gries, Katharine S., Fastenau, John, Weisel, Katja

Obtenir text complet Obtenir text complet Obtenir text complet

A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial per Dumontet, Charles, Hulin, Cyrille, Dimopoulos, Meletios A., Belch, Andrew, Dispenzieri, Angela, Ludwig, Heinz, Rodon, Philippe, Van Droogenbroeck, Jan, Qiu, Lugui, Cavo, Michele, Van de Velde, Ann, Lahuerta, Juan José, Allangba, Olivier, Lee, Jae Hoon, Boyle, Eileen, Perrot, Aurore, Moreau, Philippe, Manier, Salomon, Attal, Michel, Roussel, Murielle, Mohty, Mohamad, Mary, Jean Yves, Civet, Alexandre, Costa, Bruno, Tinel, Antoine, Gaston-Mathé, Yann, Facon, Thierry

Obtenir text complet Obtenir text complet Obtenir text complet